ENDRA Life Sciences Inc., headquartered in the United States, is a pioneering company in the medical technology industry, specialising in innovative imaging solutions. Founded in 2013, ENDRA has made significant strides in the development of its flagship product, the TAEUS™ system, which offers a unique approach to liver health assessment through advanced ultrasound technology. With a focus on enhancing diagnostic capabilities, ENDRA's core offerings stand out for their ability to provide real-time, non-invasive insights into liver fat content, a critical factor in managing metabolic diseases. The company has established a strong market position, recognised for its commitment to improving patient outcomes and streamlining clinical workflows. ENDRA Life Sciences continues to lead the way in transforming the landscape of medical imaging, particularly in the realm of liver diagnostics.
How does ENDRA Life Sciences Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ENDRA Life Sciences Inc.'s score of 23 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ENDRA Life Sciences Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, ENDRA Life Sciences Inc. has not established any significant commitments towards reducing its carbon footprint or addressing climate change. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific emissions data or commitments, ENDRA Life Sciences Inc. remains unaligned with these prevalent industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ENDRA Life Sciences Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
